FORTVITA

Trademark usage description

human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; p Read More

Vienna Information

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information

Class [005]
Human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; human pharmaceutical preparations for the relief of pain; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; anti-inflammatory pharmaceutical preparations; antiviral pharmaceutical preparations; human vaccines; antitumor drugs; antiviral drugs for treating influenza; dronabinol drugs; hypoglycemic drugs; biological preparations made from human blood cells for the treatment of cancer; biological preparations made from human blood cells for cell therapy; biological preparations made from human blood cells for use in natural killer (NK) cell immunotherapy; biological preparations made from human blood cells for use in T-cell immunotherapy; biological preparations made from living tissues for the treatment of cancer; biological preparations made from living tissues for use in cell therapy; biological preparations made from living tissues for use in immunotherapy; diagnostic preparations for clinical laboratory use; diagnostic preparations for in vitro testing for medical use; diagnostic preparations for medical laboratory use; diagnostic preparations for medical purposes for detecting genetic predispositions; biological tissue cultures for medical purposes; diagnostic chemical reagents for medical purposes.

Classification kind code

Class [042]
Chemical analysis; biological therapeutic research services; none of the aforementioned services relating to nutritional or dietary supplements.

Classification kind code

Mark Details

Serial Number

2382649

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 257 on 27^th Feb 2025	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 26^th Feb 2025	Created
Submitted for opposition 31 on 26^th Feb 2025	Formalized
Submitted for opposition 228 on 16^th Dec 2024	International Registration
Submitted for opposition 30 on 16^th Dec 2024	Filed

FORTVITA

Classification Information

Classification kind code

Class [042]Chemical analysis; biological therapeutic research services; none of the aforementioned services relating to nutritional or dietary supplements.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Chemical analysis; biological therapeutic research services; none of the aforementioned services relating to nutritional or dietary supplements.